| Literature DB >> 21277715 |
Elio Castagnola1, Maura Faraci, Francesca Fioredda, Loredana Amoroso, Francesco Risso, Alessia Franceschi, Roberto Bandettini, Gian Michele Magnano, Alessio Pini Prato, Chiara Gardella, Serena Arrigo, Marco Gattorno, Giorgio Piaggio, Antonella Ciucci, Ines Lorenzi, Anna Loy, Riccardo Haupt.
Abstract
Invasive mould infections represent important complications of different pediatric conditions. Epidemiology and clinical features vary according to the type of underlying conditions that determine the risk of invasive mycosis. No pediatric study has specifically evaluated the efficacy of prophylaxis or therapy invasive moulds infections, while pediatric dosages for the treatment of invasive aspergillosis are available for drugs that produced positive results in clinical trials undertaken in adults.Entities:
Mesh：
Year: 2011 PMID： 21277715 DOI： 10.1016/j.earlhumdev.2011.01.015
Source DB: PubMed Journal: Early Hum Dev ISSN： 0378-3782 Impact factor: 2.079